Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anatomo-radiological Study on Semilunar Line as Risk Factor fo Diastasis Recti Abdominis

NCT05162612 is registered in ClinicalTrials.gov with Marta Cavalli as lead sponsor.

NCT NCT05162612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05162612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anatomo-radiological Study on Semilunar Line as Risk Factor fo Diastasis Recti Abdominis
Lead sponsor
Marta Cavalli
Phase
Observational
Overall status
Unknown status
Start date
September 13, 2021
Completion date
September 13, 2023
Enrollment
987 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diastasis recti and weakness of the linea alba